INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Net Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹56 Cr | ₹48 Cr | ₹35 Cr | ₹20 Cr | ₹15 Cr |
What is the latest Net Current Assets ratio of INDO US BIOTECH ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹56 Cr |
Mar2023 | ₹48 Cr |
Mar2022 | ₹35 Cr |
Mar2021 | ₹20 Cr |
Mar2020 | ₹15 Cr |
How is Net Current Assets of INDO US BIOTECH Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹56 Cr | 16.82 | |
Mar2023 | ₹48 Cr | 36.64 | |
Mar2022 | ₹35 Cr | 72.77 | |
Mar2021 | ₹20 Cr | 32.97 | |
Mar2020 | ₹15 Cr | - |
Compare Net Current Assets of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹332.7 Cr | 5.4% | -12.8% | -36.6% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,669.2 Cr | -4.3% | 0.1% | 7.2% | Stock Analytics | |
KAVERI SEED COMPANY | ₹7,351.9 Cr | 3.3% | 29.3% | 96.4% | Stock Analytics | |
VENKYS (INDIA) | ₹2,340.7 Cr | -2.5% | -1.7% | -10.9% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,236.0 Cr | -5.6% | -14% | -50.4% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹433.7 Cr | -13.3% | -20% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | 5.4% |
-12.8% |
-36.6% |
SENSEX | -1.5% |
1.1% |
1.2% |
You may also like the below Video Courses